FocalTherics™ Reports Third Quarter 2026 Financial Results
FocalTherics™ Reports Third Quarter 2026 Financial Results 45% Revenue Increase and 44% Growth in U.S. Procedure Volume Year-to-date AUSTIN, Texas, Nov. 05, 2026 (GLOBE NEWSWIRE) -- FocalTherics™ (NASDAQ:FOCL) (the "Company"1), a global leader in robotic focal therapy, today announced financial results for the third quarter of 2026. Third Quarter 2026 Results and Recent Highlights Increased Revenue to $9.8 million, a 26% Increase Compared to the Prior Year Period 32% Increase in U.S. Procedure Volume over the Prior Year PeriodRecorded Seven Focal One® Capital System Sales compared to Six in the Prior Year Period, Expanded Focal One System Installed Base to 192, including 98 in the U.